LF
Therapeutic Areas
Mendus Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Vididencel (DCP-001) | Acute Myeloid Leukemia (AML) - Maintenance for MRD+ | Phase 2 |
| Ilixadencel | Solid Tumors (RCC, HCC, GIST) - Intratumoral primer | Phase 1/2 |
| Drug | Indication | Phase |
|---|---|---|
| Vididencel (DCP-001) | Acute Myeloid Leukemia (AML) - Maintenance for MRD+ | Phase 2 |
| Ilixadencel | Solid Tumors (RCC, HCC, GIST) - Intratumoral primer | Phase 1/2 |